NXS Share Price Performance
NXS Community Fair Values
- AN
Consensus Narrative from AnalystsFDA Engagement And XPERIENCE Will Secure Future Confidence
Key Takeaways Strong growth in key products and a high gross margin suggest potential for future revenue and net margin improvement. Addressing the FDA warning could enhance market confidence and stability, benefiting future earnings and stock valuation.AU$0.27FV46.1% undervalued intrinsic discount43.60%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative2users have followed this narrative2 months ago author updated this narrative
Recent NXS News & Updates
No updates
Next Science Limited Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.036
- Gross Margin
- 80.83%
- Net Profit Margin
- -46.40%
- Debt/Equity Ratio
- 52.5%
Next Science Limited Competitors
About NXS
- Founded
- 2012
- Employees
- n/a
- CEO
- WebsiteView website
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand. It offers SURGX, an antimicrobial wound Gel; acne gel; oral rinse; BACTISURE wound lavage; BlastX, an antimicrobial wound gel that provides wound management by maintaining a moist wound environment, which is conducive to wound healing; and XPERIENCE for use in cleansing and removal of debris, including microorganisms from wounds. The company was founded in 2012 and is headquartered in Sydney, Australia.
Australian Market Performance
- 7 Days: -0.2%
- 3 Months: 5.6%
- 1 Year: 8.6%
- Year to Date: 5.1%
In the last week, the market has been flat, with a notable exception in the Materials sector dropping 4.2%. As for the longer term, the market has risen 8.6% in the past 12 months. As for the next few years, earnings are expected to grow by 11% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading